Poniard cancer news

Poniard disclosed in its 1Q11 earnings that it will require additional capital to continue operations

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE